Medytox Obtains Approval for Attier HA Filler in Dominican Republic
Attier Makes Its First Entry into a Latin American Country
Medytox announced on June 24 that it has obtained product approval for its three types of Attier hyaluronic acid fillers from the General Directorate of Drugs, Food and Health Products (DIGEMAPS) in the Dominican Republic.
With this, Attier has entered a Latin American country for the first time, following its major Asian export markets such as Thailand and Indonesia. The Dominican Republic's beauty industry has shown steady growth in line with economic development and rising national income levels. In particular, the country has a high preference for Korean cosmetics and related products due to the spread of K-content.
With the newly approved Attier and 'Neuramis,' another hyaluronic acid filler that has established a presence in the Dominican Republic since 2017, Medytox has built a diverse local filler lineup. The company plans to leverage the sales and marketing expertise it has accumulated through Neuramis to ensure the successful market entry of Attier.
Hot Picks Today
Karina Fetches 6.7 Billion Won, Lives Under 24-Hour Armed Guard... World's Most Expensive Cow in the Spotlight
- "If It Breaks, That's It": Chaos Among Samsung and SK hynix Consumers... Soaring SSD Prices Mean "No Replacement, Only Refund at Original Price"
- "I'll Pay with Both Shares and Cash" vs "Cash Only"... Why Chey Taewon Filed a Further Appeal After Careful Deliberation
- Yu In-chon: "Even Sadder Than Last Year"...Bicycle Pilgrimage to Mark Brother's First Anniversary
- Do Night Runners Need Sunscreen? MFDS Says "UV from Streetlights Has Minimal Impact"
A Medytox representative stated, "Our entry into Latin America will further accelerate Attier's overseas expansion," adding, "We will continue to expand into additional countries and strengthen our position as a global filler brand."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
